| Date Filed | Type | Description |
| 10/04/2023 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 1,184 shares
@ $3.83, valued at
$4.5k
|
|
| 07/05/2023 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 151 shares
@ $4.1, valued at
$619.1 |
|
| 04/04/2023 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 480 shares
@ $3.08, valued at
$1.5k
|
|
| 01/04/2023 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 1,720 shares
@ $0.15, valued at
$258 |
|
| 10/04/2022 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 1,719 shares
@ $0.223, valued at
$383.3 |
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on VYNE Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 3,469 shares
@ $0.65, valued at
$2.3k
|
|
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2020 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 112,500 shares
@ $0
Granted 112,500 options
@ $1.95, valued at
$219.4k
|
|
| 04/07/2020 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 27,530 shares
@ $0
Granted 97,682 shares
@ $0
Paid exercise price by delivering 3,763 shares
@ $1.4, valued at
$5.3k
|
|
| 04/02/2020 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 1,940 shares
@ $2.68, valued at
$5.2k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Sold 951 shares
@ $2.35, valued at
$2.2k
|
|
| 04/03/2019 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Sold 1,696 shares
@ $3.75, valued at
$6.4k
|
|
| 01/03/2019 |
4
| Stuart Iain (Chief Scientific Officer) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 32,569 shares
@ $0
Granted 75,997 options to buy
@ $3.77, valued at
$286.5k
|
|
| 11/13/2018 |
4
| Stuart Iain (SVP R&D) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Sold 683 shares
@ $4.58, valued at
$3.1k
|
|
| 08/09/2018 |
4
| Stuart Iain (SVP R&D) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Sold 2,715 shares
@ $5.68, valued at
$15.4k
|
|
| 02/28/2018 |
4
| Stuart Iain (SVP R&D) has filed a Form 4 on Foamix Pharmaceuticals Ltd.|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $6.35, valued at
$190.5k
|
|
| 01/11/2018 |
3
| Stuart Iain (SVP R&D) has filed a Form 3 on Foamix Pharmaceuticals Ltd. |